Skip to main content
Tanya Kersten
John joe

TANYA SCHARTON-KERSTEN, PhD, RAC

President and Founder

Tanya Scharton-Kersten is a scientist and Global Regulatory Affairs Professional (20+ years and RAC). She has a PhD in Immunology; experience with bacterial, metabolic, neurologic and viral disease prevention and treatment. Focused on innovative biologics, gene therapies, and vaccines. Motivated by developing AND implementing global regulatory strategies for novel and emerging platform technologies. Engaged, get things done, risk-based decision maker and ‘doer’ for complex CMC projects.

LinkedIn

Curriculum Vitae (CV)

Publications

FEATURED PRESENTATIONS AND PUBLICATIONS

ASGCT: Common Sense Approaches

"Regulations and Science: Common Sense Approaches to Accelerating Patient Access to Novel Gene and Cell Therapies"

Presented at the 24th annual meeting of the American Society of Gene and Cell Therapy Regulations and Science,Tuesday, May 11, 2021 8:00 – 10:00 a.m

 

 

 

LINK

NIH: Bringing out new AIDS treatments

National Institutes for Health:  Strategies for Facilitating Regulatory Pathways, June 2015 (Scharton-Kersten presentation starts at 2h47m)

 

 

LINK